These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 11450170
1. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Manji HK, Moore GJ, Chen G. Br J Psychiatry Suppl; 2001 Jun; 41():s107-19. PubMed ID: 11450170 [Abstract] [Full Text] [Related]
2. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G. J Clin Psychiatry; 1999 Jun; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385 [Abstract] [Full Text] [Related]
8. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Chen G, Manji HK. Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219 [Abstract] [Full Text] [Related]
9. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK. Mol Psychiatry; 2004 Aug; 9(8):734-55. PubMed ID: 15136794 [Abstract] [Full Text] [Related]
10. Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes. Stoll AL, Severus WE. Harv Rev Psychiatry; 1996 Aug; 4(2):77-89. PubMed ID: 9384977 [Abstract] [Full Text] [Related]
11. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Manji HK, Chen G. Mol Psychiatry; 2002 Aug; 7 Suppl 1():S46-56. PubMed ID: 11986995 [Abstract] [Full Text] [Related]
12. Mood stabilizers: protecting the mood...protecting the brain. Brunello N. J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343 [Abstract] [Full Text] [Related]
13. [On the relevance of protein kinase C to lithium therapy in bipolar disorder]. Sela B. Harefuah; 2004 Jun; 143(6):414-6, 462. PubMed ID: 15524097 [Abstract] [Full Text] [Related]
15. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Manji HK, Lenox RH. Biol Psychiatry; 1999 Nov 15; 46(10):1328-51. PubMed ID: 10578449 [Abstract] [Full Text] [Related]
16. Valproate and neuroprotective effects for bipolar disorder. Atmaca M. Int Rev Psychiatry; 2009 Nov 15; 21(4):410-3. PubMed ID: 20374154 [Abstract] [Full Text] [Related]
18. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers. Teo R, King J, Dalton E, Ryves J, Williams RS, Harwood AJ. Biochem Soc Trans; 2009 Oct 18; 37(Pt 5):1110-4. PubMed ID: 19754462 [Abstract] [Full Text] [Related]
19. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Chuang DM. Ann N Y Acad Sci; 2005 Aug 18; 1053():195-204. PubMed ID: 16179524 [Abstract] [Full Text] [Related]
20. Kinases as drug targets in the treatment of bipolar disorder. Catapano LA, Manji HK. Drug Discov Today; 2008 Apr 18; 13(7-8):295-302. PubMed ID: 18405841 [Abstract] [Full Text] [Related] Page: [Next] [New Search]